Friday, 9 April 2010
Nutriset Sued Over Plumpy'Nut Patent
Wednesday, 11 November 2009
Plumpy'Nut: Tabatchnick Takes On Nutriset
Now US food company Tabatchncik Fine Foods is talking about creating its own peanut-based therapeutic food to feed severely malnourished youngsters, according to IRIN. And Tabatchnick is considering making its product open-source so anyone can copy their recipe.
From the IRIN piece, as aggregated by Reuters:
"Ben Tabatchnick, head of the family business, said his product was still in the development phase, but the patent would be "open-source", which would allow other producers to replicate his recipe.
His company "was trying to take the fear out of other producers from producing RUTF and keeping up with demand; no one producer can supply (even with licensed franchises) the world demand for RUTF and RUSF [ready-to-use supplementary foods]", he commented. "By allowing others free access (with proper oversight by UNICEF and MSF), this can and will be accomplished." "
For a quick introduction to the patent, see "What Plumpy'Nut Taught Me"
To see all my past posts and links on Plumpy'Nut, click here:
Wednesday, 5 August 2009
India Blocks Use of Plumpy'Nut
The Indian government questions whether RUTFs (ready-to-use therapeutic food) are better than hot-cooked food, as reported by the Times of India.
On that score, the government's concerns about efficacy seem overblown. Plumpy'Nut is a fortified peanut paste that has a good track record as a ready-to-use therapeutic food in several African countries. And hot cooked meals aren't going to provide the concentrated calorie and nutrient power needed in an emergency situation.
But the larger issue--of having to depend on commercial food imports should not be dismissed lightly. Yes, there's a strong whiff of protectionism but that's understandable in light of the growing crisis in the world's supply of staples. (See Lester Brown's article in Scientific American, or for an even more provocative view, this piece by Deborah Fahy Bryceson in the Monthly Review.)
The solution to the Indian impasse, as reported in the Times Online, may be to use locally produced RUTF. Two Indian companies are starting to get into the business of doing just that.
Friday, 24 July 2009
Plumpy'Nut: WBAI Radio Interview
Friday, 10 April 2009
MSF Challenges Nutriset on Plumpy'Nut
Hardly a week goes by without someone emailing me privately about Plumpy'Nut these days. One of the most recent suggested that the American Peanut Council was looking into the issue (I have not confirmed this yet). So now, in addition to the moral/philosophical/legal issue about whether Plumpy'Nut should have been patented or whether the patent would withstand a challenge is the commercial pressure that major agro-businesses might want in on the action.
Will post more as I learn more.
In the meantime, here is MSF's letter to Nutriset:
Mr. Lescanne
Director General
Nutriset
BP 35 – Le Bois Ricard
76 770 Malaunay
France
Geneva, March 24, 2009
Dear Mr. Lescanne,
I am writing to you to reaffirm the position of MSF’s Campaign for Access to Essential Medicines with respect to Nutriset’s policy on intellectual property pertaining to nutritional pastes and issues concerning the production and export of such nutritional products.
Nutriset has played, and continues to play, a major role in the development and production of products used in the battle against malnutrition, which have made a large contribution to recent developments in the handling of this pathology. A growing number of international agencies and donor countries recognize the important role of ready-to-use foods. This results in an exponential increase in the consumption of these products, which can create serious stresses in the supply chain, as was the case in the second quarter of 2008. It is becoming urgent to increase and diversify the capacity to produce nutritional pastes.
In fact, the success of treatment of malnutrition with ready-to-use foods is arousing increasing interest among producers. This is good news and offers an opportunity to support the emergence of capacity to produce these nutritional products, especially in the countries of the South. Such a development would also create the conditions for better availability and a possible reduction in their prices, which would facilitate their supply in regions of the countries affected.
Currently, Nutriset allows NGOs, as well as several manufacturers under Nutriset franchise, to produce ready-to-use foods. However, agreements of this type include restrictions and limitations that can discourage other producers. At a meeting held in Rome in March 2007 that brought together a number of international agencies working in the field of nutrition, Nutriset made a proposal addressing this problem. Nutriset contemplated granting licences to producers in the South for the manufacture and export of ready-to-use foods in return for the payment of a fair royalty in the countries where patents are in force, in parallel to its franchise system. This proposal could indeed stimulate production on a larger scale and help to lower prices. We regret that this offer was not effectively followed up on a large scale and ask that you make it public and post it on your website so that any interested producer might benefit from it.
For reasons that are obvious, the intellectual property pertaining to nutritional products of a humanitarian nature must be handled differently from that pertaining to commercial products. As you know, we believe that, in the humanitarian field of nutrition, patents should be filed only on an exceptional basis, and when they exist, licencing agreements should be offered to third parties on flexible terms and conditions, so as to ensure the widest possible availability of nutritional products of a humanitarian nature.
This is also important with respect to supplements of ready-to-use products, such as Plumpy’doz®, which was developed with the participation of Médecins Sans Frontières. If such a product were recommended for young children by providers of food aid, the needs could be exponential. The supplies required for the delivery of such nutritional products adapted to young children would only be possible in the long term through the diversification of supply.
MSF, as well as other agencies working in the battle against malnutrition, can no longer continue to depend on a single source of supply for ready-to-use products. The current position of Nutriset in this regard is a source of concern to some of these agencies, as it is to MSF. We therefore encourage Nutriset to play a key and innovative role in the management of its intellectual property by offering humanitarian licencing agreements for the production and export of ready-to-use products.
I look forward to your reply.
Yours sincerely,
Tido v. Schön-Angerer
Executive Director
Médecins Sans Frontières International
Campaign for Access to Essential Medicines
Thursday, 5 March 2009
Links: Hidden Good News, Plumpy'Nut, Malaria
The BBC reports that "Nigerian sisters, Chioma and Oluchi Ogwuegbu, have got fed up with all the bad news out of Africa. So much so that they've embarked on a journey right across Africa to try to draw attention to the good news which doesn't get reported." Go to the Ogwuegbu sisters' website at celebrateafrica.net
Paul Farmer mocks Nutriset patent on Plumpy'Nut
Ha! Farmer told me the same story a year and a half ago. It's the anecdote that got me looking into intellectual property rights and ready-to-use therapeutic foods (RUTFs). According to the Charlotte Observer's account of a recent Farmer talk, "when Partners in Health built a factory and began making its own peanut butter product, Farmer said he got "cease and desist” letters from the makers of Plumpy'nut. “It sounds crazy to argue over peanut butter,” he said. “But patenting some things goes a little too far.” " See my previous Plumpy'Nut posts for more background.
WHO cracks down on new malaria resistance
Scidev.net reports that the World Health Organization "has confirmed resistance to the malaria drug artemisinin at the Thai-Cambodia border, prompting urgent action."
Wednesday, 19 November 2008
What Plumpy’Nut Taught Me
Many were intrigued by the patent issue but didn’t want to join in publicly because they didn’t think they were expert enough. A few, no doubt, also felt the need to play it safe. After all, who knows what future employers (or donors) might think? As always, the people who knew the most were often the least interested in going on the record—in whatever format.
This is the second post in a series that started with “Rethinking Why I Blog.”
I learned about the Plumpy’Nut patent in October of 2007. I was attending a nutrition conference in which I picked up some hallway grousing from a humanitarian group that had been told it could not whip up its own version of Plumpy’nut, a carefully fortified peanut butter that has done wonders in the fight against severe malnutrition.
There was a patent on Plumpy’Nut, taken out by its manufacturer Nutriset (and the French government, I later learned.) Even though the recipe is widely available and easy to follow, making a batch on your own in many countries would land you in plenty of legal hot water.
Fascinating case. Before then the only reports I had heard or seen about Plumpy’Nut were glowing accounts about its proven qualities to save young children’s lives.
My first impulse was to dig deeper and write a freelance piece. But here I hit a snag. The rule was no freelance while on a Nieman fellowship.
So then I thought about it a bit and rather than ask for an exception, I decided to use this as an experiment in online collaboration. Normally I would hoard the information until I could come out with a fully-fledged piece. Otherwise, I would risk being scooped.
Instead, I decided to share it all, from the beginning, starting with the first disgruntled vibes I picked up at that conference. I envisioned a group blog where a bunch of interested folks could pursue the story—each contributing a different piece. And so launched what I hoped would be a group blog at Patents and Peanut Butter.
Talked to a number of students at Harvard’s School for Public Health. All were unfailingly polite, many offered suggestions, a number were intimidated by the blogging software. Most found it easier just to talk to me and let me write whatever I wanted on the blog.
Talked to several faculty members, including Richard Cash, who helped develop oral rehydration therapy back in the 1960s. Like Plumpy’Nut, ORT is a dead-simple recipe that saves lives. Unlike Plumpy’Nut, ORT is not patented. Anyone can make it. Many manufacturers do, but so do folks at home.
Several legal types thought the Plumpy’Nut patent wouldn’t stand up to legal challenge. I learned about “prior art” and “non-obvious” innovations.
Once again, the old habit—of journalist interviewing source as opposed to source commenting directly on a web site—was hard to break. I was perfectly willing to break it. But most people I talked to were not.
And so the blog sputtered along. I continued adding notes as time and opportunity allowed. But the hoped-for group blog did not materialize.
And yet, after a few months on the Internet, I did start getting inquiries and a few people from around the world added their two cents—some of them anonymously (which brings up all sorts of other issues.). Most of the interaction was still via e-mail. Most people didn’t feel comfortable posting comments on the Internet—despite repeated encouragement on my part. A few got into the spirit.
This was not the instantaneous burst of community magic that I had hoped for. But a kind of long-amplitude wave eventually did materialize. My old Plumpy’Nut posts kept getting traffic. Maybe I had brought a fast-food mentality to a slow-cooking world.
And indeed, a year after the blog went up (and many months after I stopped posting anything new), I received an e-mail from Martin Enserink at Science, who was working on a story about Plumpy’Nut and wanted to include a sidebar on the patent controversy.
We exchanged some information—though I couldn’t tell him much more than what I had already posted on the Internet. And Enserink's article—a piece of real journalism—has advanced the story. That’s where I learned, for example, that the real sticking point in the patent controversy may be the French government—and not Nutriset.
On balance, I learned more by sharing the Plumpy’Nut information when I did than if I had hoarded the information. And other people—whom I would never have known about otherwise—learned a few things through our exchanges or just by lurking on the blog.
As for news gathering, this felt kind of like a disorganized (or is it self-organized) relay race. Sometimes I was the leader passing the baton, sometimes I was receiving the baton. And sometimes, much to my surprise, I was just one of the bystanders (formerly known as the audience) cheering the race on.
Next: Authentic Sharing vs. Selfish Sharing
Monday, 20 October 2008
Science Looks at Plumpy'Nut Patent
As regular readers know, I've followed this controversy for almost exactly a year now. (See two key posts here and here.) I even started a separate blog devoted just to Plumpy'Nut and patents while at Harvard when the parameters of my fellowship did not allow me to write freelance pieces. (I quickly learned public health experts don't want to become journalists in their own right.) So I applaud any attention this issue gets from traditional media.
Two data points I want to remember from Enserink's excellent article:
". . . Nutriset and the French Institute of Research for Development obtained patents for Plumpy’nut that last until 2018 and are valid in Europe, North America, and about 30 African countries. Nutriset has threatened lawsuits to keep others—including Compact in Norway and MSI in Germany—from selling similar pastes. . . ."
and
". . . the patent [IS NOT] valid in many malnutrition hot spots, including India . . . "
As I learned in my own reporting, Enserink says it's unclear the Plumpy' Nut patent could withstand a challenge.
But I was most intrigued by what Michael Golden, the developer of an older non-patented nutritional supplement, had to say. Golden told Enserink that
"the pressure should not be on Nutriset but on the French government; [Golden] hopes that France’s foreign minister, Bernard Kouchner, a physician who helped found MSF in 1971, will intervene."
Friday, 9 May 2008
Demand for Plumpy'Nut Outstrips Supply
This from an e-mail by Jeff Johnson at Birdgsong-Peanuts (used with his permission):
. . . Demand for Plumpy Nut is many times what Nutriset and their licensees can supply, yet Nutriset won't expand production. We have asked a number of times and they refuse to grant a license outside of the countries where Plumpy Nut is used. I like using local production but the problem is demand is many times what Nutriset and the local licencees can supply. . . .
Related post:
What do patents and peanut butter have to do with starving kids?
Tuesday, 23 October 2007
What do Patents and Peanut Butter Have to do With Starving Kids?
Is Plumpy' nut another laudable example of doing well by doing good? Or will protecting the patent lead to yet another bottleneck in yet another under-served area of global health?
My interest in this topic started innocently enough with an offhand remark directed at me at a nutrition conference I attended two weeks ago.
The gist of the remark was that Nutriset, the maker of Plumpy'nut, was protecting its investment by warning other commercial enterprises, as well as humanitarian groups, not to produce their own versions of the therapeutic food. (The recipe is dead simple: so many peanuts, so much dried milk, a little oil and some vitamins and minerals. The innovation comes from realizing, among other things, that the right mix doesn't require dilution with water, which is often a problem in the developing world.)
A little search engine digging, a few e-mails and in-person conversations later, and it feels to this longtime health journalist that there is some meat in this story.
So, now I'm collecting information, original sources, suggestions for people to talk to, etc, at tightly focused web site called, straightforwardedly enough, Patents and Peanut Butter.
I'd like it to be a group effort--sort of an experiment in collaborative reporting. (I've been reading Yochai Benkler's The Wealth of Networks: How Social Production Transforms Markets and Freedom.) But am prepared to do a lot of the heavy lifting myself until things get going.
By creating a separate blog, I hope to counter some of the chaotic, hit-or-miss nature of the Web. But who knows, that may turn out to be an entirely unnecessary step. The great thing about being at Harvard for a year, is that I can try new things out while the Nieman Foundation foots the bills.